Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Molecular Oncology · 2026-05 · 20 (5) · 1161-1184
DOI: 10.1002/1878-0261.70191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 28.01.2026. Verfasst von Hsu-Min Sung und 17 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Physiology, HKP, University Medical Center, Göttingen, Germany. Hauptthemen laut MEDLINE: Killer Cells, Natural, Melanoma, Extracellular Matrix Proteins, Peroxidase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Studienstiftung des Deutschen Volkes, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Peroxidasin (PXDN), an extracellular matrix (ECM)‐associated peroxidase, has been implicated in cancer progression. However, its roles in melanoma biology and therapeutic sensitivity remain unclear. Here, we demonstrate that elevated PXDN expression is associated with poor prognosis and reduced survival in melanoma patients. Functional studies revealed that PXDN depletion impairs melanoma cell proliferation, disrupts the cell cycle, and reduces melanoma cell invasive capacities. Furthermore, we found that secreted PXDN modulates anti‐melanoma immunity by enhancing melanoma resistance to natural killer (NK)‐cell‐mediated cytotoxicity. Structural modeling identified a trimeric organization of PXDN, stabilized by disulfide‐linked peroxidase domains. Molecular dynamics simulations identified a previously unknown inhibitory interaction between the PXDN N‐terminal leucine‐rich repeat domain and the NK cell‐activating receptor NKG2‐D type II integral membrane protein (NKG2D). These findings uncover a redox‐independent role for PXDN in promoting immune evasion and tumor progression. Overall, our study highlights PXDN as a critical regulator of melanoma cell biology and a potential therapeutic target for NK‐cell‐based immunotherapy in melanoma and other solid cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Physiology, HKP, University Medical Center, Göttingen, Germany.
- VIB-VUB Center for Structural Biology, VIB, Brussels, Belgium.
- Brussels Center for Redox Biology, Brussels, Belgium.
- Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium.
- Interuniversity Institute of Bioinformatics in Brussels, ULB-VUB, Brussels, Belgium.
- Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Germany.
ORCID-Profile: Julia Malo Pueyo, Joris Messens, Ivan Bogeski
Förderung
- Deutsche Forschungsgemeinschaft
- Studienstiftung des Deutschen Volkes
- Fonds Wetenschappelijk Onderzoek
- Vrije Universiteit Brussel
- Vlaams Instituut voor Biotechnologie
- Research Foundation-Flanders-Fonds de la Recherche Scientifique
- Deutsche Forschungsgemenischaft
Zitieren
APA
Sung, H. M., Bickel, D., Krause, L. C. M., Ezeriņa, D., Ickes, C., Wojtachnia, J., Gibhardt, C. S., Shumanska, M., Wahni, K., Paluschkiwitz, A., Malo Pueyo, J., Baranova, E., Vranken, W., Stanisz, H., Stejerean-Todoran, I., Schön, M. P., Messens, J., & Bogeski, I. (2026). Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity. Molecular Oncology, 20(5), 1161-1184. https://doi.org/10.1002/1878-0261.70191
Vancouver
Sung HM, Bickel D, Krause LCM, Ezeriņa D, Ickes C, Wojtachnia J, et al. Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity. Molecular Oncology. 2026;20(5):1161-1184. doi:10.1002/1878-0261.70191
BibTeX
@article{Sung2026,
author = {Sung, Hsu-Min and Bickel, David and Krause, Lena C M and Ezeriņa, Daria and Ickes, Christian and Wojtachnia, Julian and Gibhardt, Christine S and Shumanska, Magdalena and Wahni, Khadija and Paluschkiwitz, Andrea and Malo Pueyo, Julia and Baranova, Ekaterina and Vranken, Wim and Stanisz, Hedwig and Stejerean-Todoran, Ioana and Schön, Michael P and Messens, Joris and Bogeski, Ivan},
title = {Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity},
journal = {Molecular Oncology},
year = {2026},
volume = {20},
number = {5},
pages = {1161--1184},
doi = {10.1002/1878-0261.70191}
}
EUVIMED